Article

Topography-guided therapy best for irregular corneas

Washington, DC—Topography-guided ablation (T-CAT) using the Allegretto Wave Eye-Q excimer laser (WaveLight Laser Technologie AG) offers a safe and effective primary or secondary treatment method for achieving excellent outcomes in challenging cases, said Paul H. Hughes, MD, at the annual meeting of the American Society of Cataract and Refractive Surgery.

T-CAT is performed by linking data acquired with the Allegro Topolyser to ablation with the advanced Allegretto Wave Eye-Q. The applications for this surgery include primary treatment in eyes with asymmetrical astigmatism or corneal scars, as well as in hyperopic eyes in which a decentered angle kappa may make it difficult to achieve good results with conventional ablation. In addition, T-CAT is proving very useful in complex re-treatments for eyes with decentration, small optical zones, or irregular ablations after previous excimer laser surgery, as well as in those with vision problems associated with irregular astigmatism or post prior surgery with penetrating keratoplasty (PKP) or RK, said Dr. Hughes, medical director, Southline Eye Centre, Sydney, Australia.

Dr. Hughes illustrated use of the T-CAT software and the outcomes achieved with a series of case examples, including treatment of asymmetrical astigmatism, small optical zone with or without decentered ablation, and post-PKP.

"It has been an absolute delight to treat patients who are suffering with visual symptoms after prior surgeries because we have been able to improve their quality of vision greatly, and these patients are ecstatic and grateful," Dr. Hughes said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.